Covell DG - Search Results

1

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Shoemaker RH, Scudiero DA, Melillo G, Currens MJ, Monks AP, Rabow AA, Covell DG, Sausville EA. Shoemaker RH, et al. Among authors: covell dg. Curr Top Med Chem. 2002 Mar;2(3):229-46. doi: 10.2174/1568026023394317. Curr Top Med Chem. 2002. PMID: 11944818 Review.

2

Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities.

Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Rabow AA, et al. Among authors: covell dg. J Med Chem. 2002 Feb 14;45(4):818-40. doi: 10.1021/jm010385b. J Med Chem. 2002. PMID: 11831894

3

Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.

Glover CJ, Rabow AA, Isgor YG, Shoemaker RH, Covell DG. Glover CJ, et al. Among authors: covell dg. Biochem Pharmacol. 2007 Feb 1;73(3):331-40. doi: 10.1016/j.bcp.2006.10.005. Epub 2006 Oct 13. Biochem Pharmacol. 2007. PMID: 17109823 Free PMC article.

4

Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Among authors: covell dg. Mol Cancer Ther. 2002 Mar;1(5):311-20. Mol Cancer Ther. 2002. PMID: 12489847

5

Mining the NCI screening database: explorations of agents involved in cell cycle regulation.

Wallqvist A, Monks A, Rabow AA, Thanki N, Shoemaker RH, Covell DG. Wallqvist A, et al. Among authors: covell dg. Prog Cell Cycle Res. 2003;5:173-9. Prog Cell Cycle Res. 2003. PMID: 14593711 Review.

6

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Among authors: covell dg. Bioinformatics. 2003 Nov 22;19(17):2212-24. doi: 10.1093/bioinformatics/btg302. Bioinformatics. 2003. PMID: 14630650

7

Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases.

Covell DG, Wallqvist A, Huang R, Thanki N, Rabow AA, Lu XJ. Covell DG, et al. Proteins. 2005 May 15;59(3):403-33. doi: 10.1002/prot.20392. Proteins. 2005. PMID: 15778971 Review.

8

Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.

Wallqvist A, Connelly J, Sausville EA, Covell DG, Monks A. Wallqvist A, et al. Among authors: covell dg. Mol Pharmacol. 2006 Mar;69(3):737-48. doi: 10.1124/mol.105.017061. Epub 2005 Dec 6. Mol Pharmacol. 2006. PMID: 16332985

9

Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data.

Covell DG, Wallqvist A, Rabow AA, Thanki N. Covell DG, et al. Mol Cancer Ther. 2003 Mar;2(3):317-32. Mol Cancer Ther. 2003. PMID: 12657727

10

Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure.

Keskin O, Bahar I, Jernigan RL, Beutler JA, Shoemaker RH, Sausville EA, Covell DG. Keskin O, et al. Among authors: covell dg. Anticancer Drug Des. 2000 Apr;15(2):79-98. Anticancer Drug Des. 2000. PMID: 10901296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters